Dr. Mohammed Almubarak, MD
Claim this profileWest Virginia University Healthcare
Area of expertise
Lung Cancer
Mohammed Almubarak, MD has run 8 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Mohammed Almubarak, MD has run 8 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
West Virginia University Healthcare
Wheeling Hospital/Schiffler Cancer Center
Clinical Trials Mohammed Almubarak, MD is currently running
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting
1 award
Phase 2
11 criteria
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting
1 award
Phase 2 & 3
21 criteria
More about Mohammed Almubarak, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 7 Active Clinical Trials
Treatments Mohammed Almubarak, MD has experience with
- Pembrolizumab
- Biospecimen Collection
- Ipatasertib
- Binimetinib
- Paclitaxel
- Palbociclib
Breakdown of trials Mohammed Almubarak, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mohammed Almubarak, MD specialize in?
Mohammed Almubarak, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Mohammed Almubarak, MD currently recruiting for clinical trials?
Yes, Mohammed Almubarak, MD is currently recruiting for 7 clinical trials in Morgantown West Virginia. If you're interested in participating, you should apply.
Are there any treatments that Mohammed Almubarak, MD has studied deeply?
Yes, Mohammed Almubarak, MD has studied treatments such as Pembrolizumab, Biospecimen Collection, Ipatasertib.
What is the best way to schedule an appointment with Mohammed Almubarak, MD?
Apply for one of the trials that Mohammed Almubarak, MD is conducting.
What is the office address of Mohammed Almubarak, MD?
The office of Mohammed Almubarak, MD is located at: West Virginia University Healthcare, Morgantown, West Virginia 26506 United States. This is the address for their practice at the West Virginia University Healthcare.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.